AerSale Corporation
NASDAQ:ASLEAirlines, Airports & Air Services
-$0.11 today
- Market cap
- $242.47M
- Beta
- 0.27
- P/E (TTM)
- 25.5
- EPS (TTM)
- $0.25
Volume 0.30M
Average 0.37M
ASLE Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
AerSale CorporationNASDAQ: ASLE
Operating Margin · Q1 FY2026 · quarter ended Mar 2026
Operating margin widens to -4.7%
Operating margin was -4.7% in Q1 FY2026, up 5.4 pp from a year earlier. On a trailing-twelve-month basis it was 5.6%, up 6.1 pp year over year. Over 3 fiscal years it narrowed by 8.8 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
What to watch
Whether operating margin reaches the consensus estimate from 1 analysts of 2.4% for the fiscal year ending Dec 2026, down from 4.7% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -4.7%-12.5 pp QoQ
- Last fiscal yearDec 2025
- 4.7%+1.9 pp YoY
- LTMMar 2026
- 5.6%+6.1 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.4 pp | -3.6 pp | -9.0 pp |
| 1 year | +1.9 pp | -2.3 pp | -4.2 pp |
| 3 years | -8.8 pp | +3.5 pp | +12.3 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 4.7%
- Year-over-year change
- +1.9pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.7% | +1.9pp |
| FY2024 | 2024-12-31 | 2.8% | +6.0pp |
| FY2023 | 2023-12-31 | -3.2% | -16.7pp |
| FY2022 | 2022-12-31 | 13.5% | -3.2pp |
| FY2021 | 2021-12-31 | 16.6% | — |
Operating Margin vs competitors
How ASLE compares with its peers on the latest reported figures
- ASLE's LTM Mar 2026 operating margin of 5.6% is the 5th highest of the 10 companies compared; the peer median is 3.3%.
- Its year-over-year change of +6.1 pp is the 2nd highest of 10, against a peer median of +0.6 pp.
- Over three fiscal years its change of -8.8 pp compares with a peer median of -1.0 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 54.9% | +4.3 pp | — | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | 36.0% | +0.6 pp | +27.3 pp |
| LTM Mar 2026 | 18.4% | +3.3 pp | +0.0 pp | |
| LTM Apr 2026 | 11.3% | -0.5 pp | -1.9 pp | |
| LTM Mar 2026 | 5.6% | +6.1 pp | -8.8 pp | |
| LTM Mar 2026 | 3.3% | -0.4 pp | +1.1 pp | |
| LTM Mar 2026 | 2.6% | +0.6 pp | +7.2 pp | |
| LTM Mar 2026 | -1.6% | -8.6 pp | -5.5 pp | |
| LTM Mar 2026 | -11.1% | +10.1 pp | -9.4 pp | |
| LTM Mar 2026 | -122.0% | -39.4 pp | -9.9 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding ASLE) | 3.3% | +0.6 pp | -1.0 pp | |
Competitors are the stored peer set for ASLE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 340.44M | 408.54M | 334.5M | 345.07M | 335.29M |
| Cost of Revenue | 221.05M | 257.15M | 242.08M | 241.13M | 229.51M |
| Gross Profit | 119.39M | 151.39M | 92.42M | 103.94M | 105.77M |
| Gross Margin | 35.1% | 37.1% | 27.6% | 30.1% | 31.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 77.5M | 96.35M | 103.19M | 94.19M | 89.98M |
| Operating Expenses | 62.73M | 96.35M | 103.19M | 94.19M | 89.98M |
| Depreciation & Amortization | 13M | 10.98M | 10.82M | 16.41M | 19.33M |
| EBITDA | 61.75M | 66.89M | 3.14M | 29.95M | 38.19M |
| EBITDA Margin | 18.1% | 16.4% | 0.9% | 8.7% | 11.4% |
| Operating Income | 56.66M | 55.05M | (10.77M) | 9.74M | 15.79M |
| Operating Margin | 16.6% | 13.5% | -3.2% | 2.8% | 4.7% |
| Interest Income | 0 | 0 | 155K | 0 | 0 |
| Interest Expense | 980K | 0 | 0 | 5.7M | 8.33M |
| Other Income / Expenses | (8.89M) | 2.84M | 3.09M | (1.91M) | (5.26M) |
| Income Before Tax | 47.77M | 57.88M | (7.68M) | 7.84M | 10.53M |
| Pre-Tax Margin | 14.0% | 14.2% | -2.3% | 2.3% | 3.1% |
| Income Tax Expense | 11.66M | 14.02M | (2.12M) | 1.99M | 1.95M |
| Net Income | 36.12M | 43.86M | (5.56M) | 5.85M | 8.58M |
| Net Margin | 10.6% | 10.7% | -1.7% | 1.7% | 2.6% |
| EPS (Basic) | 0.84 | 0.85 | (0.15) | 0.11 | 0.18 |
| EPS (Diluted) | 0.76 | 0.83 | (0.15) | 0.11 | 0.18 |
| Weighted Avg Shares | 43.19M | 51.57M | 51.29M | 53.11M | 47.2M |
| Weighted Avg Shares (Diluted) | 47.31M | 53.15M | 51.46M | 53.36M | 47.77M |
AerSale Corporation
NASDAQ:ASLE
Intrinsic Alpha fair value
Locked
Current Price
$5.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.